Insulin Resistance is Associated with Gut Permeability Without the Direct Influence of Obesity in Young Adults

Lusikelelwe Mkumbuzi, Mvuyisi M O Mfengu, Godwill A Engwa, Constance R Sewani-Rusike, Lusikelelwe Mkumbuzi, Mvuyisi M O Mfengu, Godwill A Engwa, Constance R Sewani-Rusike

Abstract

Objective: Recent findings have associated insulin resistance and obesity with increased gut permeability. However, it still remains unclear whether obesity may be the underlining factor for the association between gut permeability and insulin resistance. This study investigated the relationship between gut permeability, measures of obesity, and markers of insulin resistance in young adults.

Materials and methods: A cross-sectional quantitative study which enrolled 151 young South African adults was conducted. Anthropometric measurements were performed to assess obesity. Adiponectin, leptin, and zonulin, a marker for gut permeability, were assayed. Insulin and fasting glucose were assayed and used to determine insulin resistance (HOMA-IR), insulin sensitivity (%S) and beta cell function (%B).

Results: Decreased adiponectin and increased leptin were associated (p<0.05) with obesity. HOMA-IR inversely correlated (p<0.05) with adiponectin but positively with leptin to adiponectin (Lept/ADP) ratio (p<0.05) in females. Markers of insulin resistance were not associated (p>0.05) with obesity. Overweight/obese (O/O) females had a significantly (p<0.01) higher zonulin concentration than lean females. Zonulin positively associated (p<0.05) with body mass index and visceral fat, as well as with HOMA-IR and insulin concentration. Lept/ADP ratio, an inflammatory marker, was associated with risk of insulin resistance. Increased insulin, a maker for insulin resistance, was associated with risk of gut permeability.

Conclusion: Insulin resistance was associated with gut permeability without a direct influence by obesity in young adults. The lack of relationship between obesity and insulin resistance was possibly mediated by the contribution of obesity to gut permeability. This finding suggests that gut permeability may be a potential independent risk factor for the development of insulin resistance in healthy obese young adults.

Keywords: gut permeability; inflammation; insulin resistance; obesity.

Conflict of interest statement

The authors report no conflicts of interest for this work.

© 2020 Mkumbuzi et al.

Figures

Figure 1
Figure 1
Plasma adiponectin level between overweight/obese and lean subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, *p

Figure 2

Plasma leptin level between overweight/obese…

Figure 2

Plasma leptin level between overweight/obese and lean subjects. Data is expressed as mean…

Figure 2
Plasma leptin level between overweight/obese and lean subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, *p

Figure 3

Leptin to adiponectin ratio between…

Figure 3

Leptin to adiponectin ratio between overweight/obese and lean subjects. Data is expressed as…

Figure 3
Leptin to adiponectin ratio between overweight/obese and lean subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, ***p

Figure 4

Plasma zonulin between lean and…

Figure 4

Plasma zonulin between lean and overweight/obese subjects. Data is expressed as mean ±…

Figure 4
Plasma zonulin between lean and overweight/obese subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, **p

Figure 5

Mediation effect and summary of…

Figure 5

Mediation effect and summary of findings. ( A ) Mediation effect of gut…

Figure 5
Mediation effect and summary of findings. (A) Mediation effect of gut permeability on the relationship between obesity and insulin resistance. The numeric figures represent the coefficient of relationship; X: Independent variable, Y: Dependent variable and M: Mediator variable. (B) Schematic summary of findings. A: Metabolically healthy obesity in young adults promote gut and systemic inflammation; B: Inflammation in the gut promotes gut permeability; C: Gut permeability leads to insulin resistance; D: Systemic inflammation promotes insulin resistance; E: Metabolically healthy obesity in young adults is associated with gut permeability; F: Metabolically healthy obesity in young adults is not associated with insulin resistance.
Similar articles
Cited by
References
    1. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Nm J Clin Invest. 2016;126(1):12–22. doi:10.1172/JCI77812 - DOI - PMC - PubMed
    1. Gutiérrez-Rodelo C, Roura-Guiberna A, Olivares-Reyes JA. Molecular mechanisms of insulin resistance: an update. Gac Med Mex. 2017;153:197–209.
    1. Eltom MA, Ahmed MH. Increasing prevalence of type diabetes mellitus of ethnicity in Northern Sudan. Diabetes Res Clin Pract. 2018;136:93–99. doi:10.1016/j.diabres.2017.11.034 - DOI - PubMed
    1. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Int Diabetes Fed; 2015. Available from:: http://www.idf.org/diabetesatlas. Accessed January2, 2016.
    1. SEMDSA Type 2 Diabetes Guidelines Expert Committee. The 2017 SEMDSA guideline for the management of type 2 diabetes. JEMDSA. 2017;22(1):S1–S196.
Show all 44 references
Related information
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 2
Figure 2
Plasma leptin level between overweight/obese and lean subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, *p

Figure 3

Leptin to adiponectin ratio between…

Figure 3

Leptin to adiponectin ratio between overweight/obese and lean subjects. Data is expressed as…

Figure 3
Leptin to adiponectin ratio between overweight/obese and lean subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, ***p

Figure 4

Plasma zonulin between lean and…

Figure 4

Plasma zonulin between lean and overweight/obese subjects. Data is expressed as mean ±…

Figure 4
Plasma zonulin between lean and overweight/obese subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, **p

Figure 5

Mediation effect and summary of…

Figure 5

Mediation effect and summary of findings. ( A ) Mediation effect of gut…

Figure 5
Mediation effect and summary of findings. (A) Mediation effect of gut permeability on the relationship between obesity and insulin resistance. The numeric figures represent the coefficient of relationship; X: Independent variable, Y: Dependent variable and M: Mediator variable. (B) Schematic summary of findings. A: Metabolically healthy obesity in young adults promote gut and systemic inflammation; B: Inflammation in the gut promotes gut permeability; C: Gut permeability leads to insulin resistance; D: Systemic inflammation promotes insulin resistance; E: Metabolically healthy obesity in young adults is associated with gut permeability; F: Metabolically healthy obesity in young adults is not associated with insulin resistance.
Similar articles
Cited by
References
    1. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Nm J Clin Invest. 2016;126(1):12–22. doi:10.1172/JCI77812 - DOI - PMC - PubMed
    1. Gutiérrez-Rodelo C, Roura-Guiberna A, Olivares-Reyes JA. Molecular mechanisms of insulin resistance: an update. Gac Med Mex. 2017;153:197–209.
    1. Eltom MA, Ahmed MH. Increasing prevalence of type diabetes mellitus of ethnicity in Northern Sudan. Diabetes Res Clin Pract. 2018;136:93–99. doi:10.1016/j.diabres.2017.11.034 - DOI - PubMed
    1. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Int Diabetes Fed; 2015. Available from:: http://www.idf.org/diabetesatlas. Accessed January2, 2016.
    1. SEMDSA Type 2 Diabetes Guidelines Expert Committee. The 2017 SEMDSA guideline for the management of type 2 diabetes. JEMDSA. 2017;22(1):S1–S196.
Show all 44 references
Related information
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 3
Figure 3
Leptin to adiponectin ratio between overweight/obese and lean subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, ***p

Figure 4

Plasma zonulin between lean and…

Figure 4

Plasma zonulin between lean and overweight/obese subjects. Data is expressed as mean ±…

Figure 4
Plasma zonulin between lean and overweight/obese subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, **p

Figure 5

Mediation effect and summary of…

Figure 5

Mediation effect and summary of findings. ( A ) Mediation effect of gut…

Figure 5
Mediation effect and summary of findings. (A) Mediation effect of gut permeability on the relationship between obesity and insulin resistance. The numeric figures represent the coefficient of relationship; X: Independent variable, Y: Dependent variable and M: Mediator variable. (B) Schematic summary of findings. A: Metabolically healthy obesity in young adults promote gut and systemic inflammation; B: Inflammation in the gut promotes gut permeability; C: Gut permeability leads to insulin resistance; D: Systemic inflammation promotes insulin resistance; E: Metabolically healthy obesity in young adults is associated with gut permeability; F: Metabolically healthy obesity in young adults is not associated with insulin resistance.
Similar articles
Cited by
References
    1. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Nm J Clin Invest. 2016;126(1):12–22. doi:10.1172/JCI77812 - DOI - PMC - PubMed
    1. Gutiérrez-Rodelo C, Roura-Guiberna A, Olivares-Reyes JA. Molecular mechanisms of insulin resistance: an update. Gac Med Mex. 2017;153:197–209.
    1. Eltom MA, Ahmed MH. Increasing prevalence of type diabetes mellitus of ethnicity in Northern Sudan. Diabetes Res Clin Pract. 2018;136:93–99. doi:10.1016/j.diabres.2017.11.034 - DOI - PubMed
    1. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Int Diabetes Fed; 2015. Available from:: http://www.idf.org/diabetesatlas. Accessed January2, 2016.
    1. SEMDSA Type 2 Diabetes Guidelines Expert Committee. The 2017 SEMDSA guideline for the management of type 2 diabetes. JEMDSA. 2017;22(1):S1–S196.
Show all 44 references
Related information
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 4
Figure 4
Plasma zonulin between lean and overweight/obese subjects. Data is expressed as mean ± standard error of the mean. p≤0.05 was considered statistically significant, **p

Figure 5

Mediation effect and summary of…

Figure 5

Mediation effect and summary of findings. ( A ) Mediation effect of gut…

Figure 5
Mediation effect and summary of findings. (A) Mediation effect of gut permeability on the relationship between obesity and insulin resistance. The numeric figures represent the coefficient of relationship; X: Independent variable, Y: Dependent variable and M: Mediator variable. (B) Schematic summary of findings. A: Metabolically healthy obesity in young adults promote gut and systemic inflammation; B: Inflammation in the gut promotes gut permeability; C: Gut permeability leads to insulin resistance; D: Systemic inflammation promotes insulin resistance; E: Metabolically healthy obesity in young adults is associated with gut permeability; F: Metabolically healthy obesity in young adults is not associated with insulin resistance.
Figure 5
Figure 5
Mediation effect and summary of findings. (A) Mediation effect of gut permeability on the relationship between obesity and insulin resistance. The numeric figures represent the coefficient of relationship; X: Independent variable, Y: Dependent variable and M: Mediator variable. (B) Schematic summary of findings. A: Metabolically healthy obesity in young adults promote gut and systemic inflammation; B: Inflammation in the gut promotes gut permeability; C: Gut permeability leads to insulin resistance; D: Systemic inflammation promotes insulin resistance; E: Metabolically healthy obesity in young adults is associated with gut permeability; F: Metabolically healthy obesity in young adults is not associated with insulin resistance.

References

    1. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Nm J Clin Invest. 2016;126(1):12–22. doi:10.1172/JCI77812
    1. Gutiérrez-Rodelo C, Roura-Guiberna A, Olivares-Reyes JA. Molecular mechanisms of insulin resistance: an update. Gac Med Mex. 2017;153:197–209.
    1. Eltom MA, Ahmed MH. Increasing prevalence of type diabetes mellitus of ethnicity in Northern Sudan. Diabetes Res Clin Pract. 2018;136:93–99. doi:10.1016/j.diabres.2017.11.034
    1. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Int Diabetes Fed; 2015. Available from:: . Accessed January2, 2016.
    1. SEMDSA Type 2 Diabetes Guidelines Expert Committee. The 2017 SEMDSA guideline for the management of type 2 diabetes. JEMDSA. 2017;22(1):S1–S196.
    1. Wu Y, Ding Y, Tanaka Y, Zhang W. Review risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185–1200. doi:10.7150/ijms.10001
    1. Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue an endocrine gland. Arch Med Sci. 2013;9(2):191–200. doi:10.5114/aoms.2013.33181
    1. Francisco V, Pino J, Campos-Cabaleiro V, et al. Obesity, fat mass and immune system: role for leptin. Front Physiol. 2018;9:640. doi:10.3389/fphys.2018.00640
    1. Facey A 1, Dilworth L, Irving R. A review of the leptin hormone and the association with obesity and diabetes mellitus. J Diabetes Metab. 2017;8:3. doi:10.4172/2155-6156.100072
    1. Gariballa S, Alkaabi J, Yasin J, Al Essa A. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr Disord. 2019;19(1):55. doi:10.1186/s12902-019-0386-z
    1. Rudnicki M, Abdifarkosh G, Rezvan O, Nwadozi E, Roudier E, Haas TL. Female mice have higher angiogenesis in perigonadal adipose tissue than males in response to high-fat diet. Front Physiol. 2018;9:1452. doi:10.3389/fphys.2018.01452
    1. Martins LM, Oliveira ARS, Cruz KJC, Torres-Leal FL, Marreiro DN. Obesity, inflammation, and insulin resistance. Braz J Pharm Sci. 2014;50(4):677–685. doi:10.1590/S1984-82502014000400003
    1. Kang YE, Kim JM, Joung KH, et al. The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction. PLoS One. 2016;11:4.
    1. Torres-Leal FL, Fonseca-Alaniz MH, Rogero MM, Tirapegui J. The role of inflamed adipose tissue in the insulin resistance. Cell Biochem Funct. 2010;28(8):623–631. doi:10.1002/cbf.1706
    1. Finucane FM, Luan J, Wareham NJ, et al. Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia. 2009;52(11):2345–2349. doi:10.1007/s00125-009-1508-3
    1. Liu C, Feng X, Li Q, Wang Y, Li Q, Hua M. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis. Cytokine. 2016;86:100–109. doi:10.1016/j.cyto.2016.06.028
    1. Saad MJA, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology. 2016;31(4):283–293. doi:10.1152/physiol.00041.2015
    1. Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J Parenter Enteral Nutr. 2012;35:14–20. doi:10.1177/0148607111413772
    1. Amar J, Chabo C, Waget A, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. 2011;3:559–572. doi:10.1002/emmm.201100159
    1. Teixeira TDS, Collado MC, Ferreira CLLF, Bressan J, Peluzio MCG. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nut Res. 2012;32:637–647. doi:10.1016/j.nutres.2012.07.003
    1. Damms-Machado A, Louis S, Schnitzer A, et al. Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction. Am J Clin Nutr. 2017;105(1):127–135. doi:10.3945/ajcn.116.131110
    1. Jung U, Choi M. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and non-alcoholic fatty liver disease. Int J Mol Sci. 2014;215:6184–6223. doi:10.3390/ijms15046184
    1. Refaie MR, Sayed-Ahmed NA, Bakr AM, Abdel Aziz MY, Abdel-Gawad SS, Kannishi MH. Aging is an inevitable risk factor for insulin resistance. J Taibah Univ Sci. 2006;1(1):30–41. doi:10.1016/S1658-3612(06)70005-1
    1. Karakelides H, Irving BA, Short KR, O’Brien P, Nair KS. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes. 2010;59(1):89–97. doi:10.2337/db09-0591
    1. Stewart A, Marfell-Jones M, Olds T, Ridder H. International Standards for Anthropometric Assessment. Lower Hutt: ISAK; 2011.
    1. Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut‐offs for thinness, overweight and obesity. Pediatr Obes. 2012;7(12):284–294.
    1. Anhê FF, Roy D, Pilon G, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;64(6):872–883. doi:10.1136/gutjnl-2014-307142
    1. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015;11(10):577. doi:10.1038/nrendo.2015.128
    1. Belkina AC, Denis GV. Obesity genes and insulin resistance. Curr Opin Endocrinol Diabetes Obes. 2010;17(5):472–477. doi:10.1097/MED.0b013e32833c5c48
    1. Rossouw HA, Grant CC, Viljoen M. Overweight and obesity in children and adolescents: the South African problem. S Afr J Sci. 2012;108(5/6):31–37. doi:10.4102/sajs.v108i5/6.907
    1. Lee YS, Osborne O, Youngoh D, et al. Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell. 2014;157(6):1339–1352. doi:10.1016/j.cell.2014.05.012
    1. Forny-Germano L, De Felice FG, Vieira MN. The role of leptin and adiponectin in obesity-associated cognitive decline and alzheimer’s disease. Front Neurosci. 2019;12:1027. doi:10.3389/fnins.2018.01027
    1. Wu H, Ballantyne CM. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127(1):43–54. doi:10.1172/JCI88880
    1. Wensveen FM, Jelenčić V, Valentić S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16(4):376. doi:10.1038/ni.3120
    1. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
    1. Singh Y, Garg MK, Tandon N, Marwaha RK. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol. 2013;5(4):245–251. doi:10.4274/Jcrpe.1127
    1. Johnson W. Healthy obesity: time to give up the ghost? Ann Hum Biol. 2018;45(4):297–298. doi:10.1080/03014460.2018.1444789
    1. Calori G, Lattuada G, Piemonti L. Prevalence, metabolic features and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care. 2011;34(1):210–215. doi:10.2337/dc10-0665
    1. Stefan N, Kantartzis K, Machann J. Identification and characterization of metabolically begin obesity in humans. Arch Intern Med. 2008;168:1609–1616. doi:10.1001/archinte.168.15.1609
    1. Moreno-Navarete JM, Sabater M, Ortega F, Ricart W, Fernández-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One. 2012;7:e37160. doi:10.1371/journal.pone.0037160
    1. Salvo-Romero E, Alonso-Cotoner C, Pardo-Camacho C, Casado-Bedmar M, Vicario M. The intestinal barrier function and its involvement in digestive disease. Rev Esp Enferm Dig. 2015;107:686–696. doi:10.17235/reed.2015.3846/2015
    1. Winer DA, Luck H, Tsai S, Winer S. The intestinal immune system in obesity and insulin resistance. Cell Metab. 2016;23(3):413–426. doi:10.1016/j.cmet.2016.01.003
    1. Ohlsson B, Orho-Melander M, Nilsson P. Higher levels of serum zonulin may rather be associated with increased risk of obesity and hyperlipidemia, than with gastrointestinal symptoms or disease manifestations. Int J Mol Sci. 2017;18(3):582. doi:10.3390/ijms18030582
    1. Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4):e1251384. doi:10.1080/21688370.2016.1251384

Source: PubMed

3
Suscribir